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Abstract Magnetic resonance imaging (MRI) is the
examination method of choice for the diagnosis of a variety
of diseases. MRI allows us to obtain not only anatomical
information but also identification of physiological and
functional parameters such as networks in the brain and
tumor cellularity, which plays an increasing role in onco-
logic imaging, as well as blood flow and tissue perfusion.
However, in many cases such as in epilepsy, degenerative
neurological diseases and oncological processes, additional
metabolic and molecular information obtained by PET can
provide essential complementary information for better
diagnosis. The combined information obtained from MRI
and PET acquired in a single imaging session allows a
more accurate localization of pathological findings and
better assessment of the underlying physiopathology, thus
providing a more powerful diagnostic tool. Two hundred
and twenty-one patients were scanned from April 2011 to
January 2012 on a Philips Ingenuity TF PET/MRI system.
The purpose of this review article is to provide an overview
of the techniques used for the optimization of different
protocols performed in our hospital by specialists in the
following fields: neuroradiology, head and neck, breast,
and prostate imaging. This paper also discusses the dif-
ferent problems encountered, such as the length of studies,
motion artifacts, and accuracy of image fusion including
physical and technical aspects, and the proposed solutions.
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Introduction
It was during the 1990s that Woods and Shao used PET/
MRI in small animals for the first time [1, 2], but it was not
before 2006 that the first simultaneous MRI and PET
images of the human brain were acquired [3, 4]. The main
difficulty when using these two techniques together is the
interference between the two scanners, resulting in elec-
tromagnetic interference of the PET readout electronics
with the MRI system and failure of the PET photomulti-
plier tubes in the magnetic field of the MRI machine [5].
Two different kinds of hybrid PET/MRI systems are cur-
rently on the market: one with a sequential acquisition mode
(Philips Ingenuity TF PET/MRI) and another with a simul-
taneous MRI and PET acquisition technique (Siemens Bio-
graph mMR, Erlangen, Germany). A third sequential imaging
system also available consists of two scanners located in two
separate rooms where the patient is transferred from the
examination bed of one scanner to the other through a
‘‘shuttle’’ system. In our hospital we implemented a sequential
hybrid PET/MRI that combines a 3T MRI and a time-of-flight
PET scanner (Philips Ingenuity TF PET/MRI), separated by
approximately 3 meters and located on each side of the
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examination table. The design and the performance of this
device are described in detail in a recent publication [6]. In a
clinical environment, a diagnostic MRI is first acquired, fol-
lowed by MRI images for PET attenuation correction after
which the patient is moved into the PET scanner for scanning.
While this design does not allow simultaneous acquisition of
the two modalities, it resembles current PET/CT scanners in
its design. Provided that the patient does not move between
imaging studies, it allows accurate fusion of coregistered PET
and MRI sequences acquired sequentially.
The current paper comprises an overview of optimized
clinical protocols for different organs using our sequential
hybrid PET/MRI system. Particular attention is given to
problems encountered in a clinical setting and their solu-
tions, as used by specialists in neuroradiology, head and
neck and breast oncology, and prostate imaging.
The major advantage in using these two techniques
together consists in effectively combining the complex
information from the two modalities, therefore potentially
allowing a more accurate diagnosis. On one hand, MRI
allows us not only to obtain anatomical information but
currently enables identification of networks in the brain and
functional imaging. The study of metabolism in tumors and
epilepsy is possible with the utilization of sequences such
as perfusion without contrast media using arterial spin
labeling [7], with classic susceptibility perfusion and with
diffusion-weighted imaging (DWI). However, in many
cases such as in epilepsy, neurodegenerative diseases and
oncological processes [8], PET imaging can provide
additional metabolic and molecular information that can be
valuable for a more accurate diagnosis [9, 10].
A variety of problems and technical challenges were
encountered during the optimization of clinical protocols:
first, those inherent to the scanner hardware itself, second,
those caused by the long duration of studies, and third,
related to the required training of medical and technical staff
from the radiology and nuclear medicine departments. The
duration of the study has an important impact on patient
comfort and thereby on potential motion artifacts and is also
associated with changes in the biodistribution of radiotra-
cers, such as their accumulation in the bladder, which affects
correct interpretation of image fusion in the pelvic area.
The first part of this review article describes general
practical problems and technical challenges that can be
encountered in clinical application of this new hybrid
technique, and the second part focuses on issues that are
specific to each organ system or clinical specialty.
Patient population
Two hundred and twenty-one patients (133 males; 88
females, mean age 59.7 years, range 7–90 years) were
scanned from April 2011 to January 2012. The anatomical
regions evaluated were as follows: abdominal = 7,
heart = 11, brain = 29, whole body = 31, head and neck
= 27, breast and female pelvis = 46 and prostate = 70.
Scanning time and sequential PET/MRI protocols
The imaging protocols for the current PET/MRI system
were developed in analogy to clinical MRI protocols used
to assess diseases in various anatomical regions. As in
clinical routine, an MRI examination may last between 30
and 70 min depending on the indication and the additional
use of functional sequences. Simply adding an additional
total body MRI for attenuation correction, total body
diagnostic MRI sequences, and a total body PET acquisi-
tion would result in an unacceptably long examination time
in clinical practice. Consequently, all protocols had to be
shortened while maintaining diagnostic quality. In our
institution, imaging protocols and quality control of PET/
MRI exams are managed jointly by the senior radiologist
and the senior nuclear medicine specialist, who also
supervise senior residents in training who are present at the
scanner console during the examination. Due to the
importance of quality control and complexity of imaging
protocols, technicians are instructed to check with attend-
ing physicians for the diagnostic adequacy of the study
before discharging the patient. The attending staff then
checks image quality and decide whether additional
sequences may be required or if additional optional
sequences available for a given protocol may be unneces-
sary. Despite this continuous monitoring of the examina-
tion by the attending staff, the total examination time
including patient positioning, injection of radiotracer, MRI
acquisition, table rotation, and PET scanning was on
average 2.33 h (range: 1.52–3.08 h). In our series, the total
examination time varied depending on the anatomical
region being examined as follows: abdomen = 2.07,
heart = 2.27, brain = 2.46, whole body = 2.07, head and
neck = 3.08, prostate = 2.53, breast = 1.52, uterus and
ovaries = 2.09.
PET imaging
The administered radiotracer activities have been estab-
lished for the different indications following international
guidelines and previous publications [11–14] and are in
agreement with the national Swiss diagnostic reference
levels.
The acquisition time was adapted to the different pro-
tocols: longer acquisition time was used on specific organs,
depending on the clinical indication, while the shortest
acquisition time recommended by the vendor (1 min 20 s)
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was used for whole body imaging. The datasets were
reconstructed using a 3D listmode-based TOF ordered
subset expectation maximization (OSEM) algorithm with
33 subsets and 3 iterations and a reconstruction resolution
of 4 mm.
It should be noted that for the Gemini PET system, the
time-of-flight technology and the use of an overlap of 50 %
of bed positions allow shorter acquisition times as recom-
mended [14].
The attenuation correction procedure, which is MR-
based, is described in detail in a recent publication [6]. The
attenuation map is obtained by automatic anatomical seg-
mentation obtained from a specific whole-body MR
sequence, consisting of a fast multi-stack spoiled T1-
weighted gradient echo whole-body protocol that takes
about 3 min for a 100 cm axial coverage. According to our
standard protocol, this sequence is performed systemati-
cally just before table rotation and PET acquisition, in
order to minimize artifacts due to motion and possible
misregistration. A schematic representation of a PET/MRI
acquisition is provided in Fig. 1.
Specific imaging protocols:
An overview of the specific protocols used for the PET/
MRI acquisitions in different anatomic areas is given in
Table 1.
Neuroradiology
Indications for hybrid imaging were: tumors (Fig. 2) (n =
11), epilepsy (Fig. 3) (n = 10), and neurodegenerative
diseases (n = 8). Depending on the clinical indication as
mentioned above, the protocols (Table 1) included: spin
echo T1-weighted images (SET1, TE 10 ms, TR 520 ms,
slice thickness 4 mm), Turbo spin echo T2-weighted
images (FSET2 TE 100 ms, TR 4,000 ms, slice thickness
4 mm), 3D Fluid attenuated inversion recovery (3D
FLAIR, TE 300 ms, TR 4,800 ms, slice thickness 1 mm),
arterial spin labeling (ASL, TE 14 ms, TR 300 ms), classic
susceptibility perfusion and diffusion tensor imaging (DTI,
TE 72 ms, TR 7,800 ms, 30 directions) using an 8-channel
brain coil.
For the evaluation of the resting glucose metabolism in
the brain we administered 250 MBq of FDG in a dimly lit
room with the patient in a supine position and 30 min later,
we acquired a static brain PET acquisition lasting
10–15 min [12].
For brain tumor staging, we acquired a 10 min static
brain PET acquisition 30 min after injection of 200 MBq
of 18F-Fluoro Ethyl Tyrosine (FET) [11]: the uptake phase
was performed while the patient was in the PET/MRI
tomograph and was used for acquiring MRI sequences in
order to shorten total scanning duration. The datasets were
reconstructed using a 3D RAMLA [15] algorithm and a
reconstruction resolution of 2 mm. Fusion of the MRI
sequence and PET data was done routinely using the
dedicated PET/MRI software (Philips Fusion Viewer on
Extended BrillianceTM Workspace), as well as OsiriX
medical imaging software (OsiriX v4.0 64bits; Geneva,
Switzerland).
Head and neck
The indications in head and neck imaging included staging of
primary and recurrent tumors (Figs. 4, 5) (n = 20) and fol-
low-up of patients with high risk of recurrence after com-
bined chemoradiotherapy with or without surgery (n = 7).
The MRI examination of the head and neck area was done
prior to the PET acquisition, starting immediately after the
administration of the radiotracer. The duration of all head
and neck MR sequences was 40–45 min. The protocol con-
cept was similar to the one validated on other MR machines
used clinically for head and neck oncology in our depart-
ment. The coil used was the standard 16-channel head and
neck phased array coil. The sequences performed routinely
included: axial T1- (TE 16 ms, TR 683 ms) and T2 (TE
90 ms, TR 3528 ms)-weighted high resolution turbo spin
echo sequences, a coronal STIR sequence (TE 80 ms, TR
5040 ms) an axial echo planar diffusion-weighted sequence
(TE 260 ms, TR 3876 ms), and post-injection of Gadolinium
chelates, axial and coronal T1-weighted turbo spin echo
sequences, a 3D THRIVE (TE 6.9 ms and TR 3,4 ms) and a
3D T1 Dixon sequence (TE1 1,11 ms; TE 2 2,0 ms, TR
3,3 ms). The slice thickness for the turbo spin echo
sequences was 3–4 mm, for the 3D Thrive sequence 0.6 and
Fig. 1 PET/MRI workflow. The study typically begins with the
acquisition of MRI sequences during the PET uptake time in order to
reduce the overall duration of the exam (for details see text). After the
diagnostic MRI, an MRI attenuation correction sequence is per-
formed. Subsequently the table is rotated in order to acquire the PET
images. If additional MRI sequences are necessary, a second table
rotation to the MR position is realized followed by a second set of
MRI acquisitions. Depending on the clinical indication, dedicated
MRI coils are used
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Table 1 Principal parameters in the optimization of workflow for a sequential MR-PET scanner
Organs Clinical indications Sequences Plane TR/TE (ms)
Res (mm)
Routine
sequences
fusion
Total
scanning
time (hours)b
Total
examination
time (hours)
Brain Tumor, epilepsy, and
neurodegenerative diseases
FSE T2 Axial 4000/100
0.34/0.34/4.00
3DT1 ? C,
3DFLAIR
1h00 2.46
SET1 -/? C Axial 520/10
0.3/03/4.00
DTI Axial 7800/72
1.88/1.88/2.00
3D FLAIR 3D 4800/300
1.1./1.10
ASL Axial 300/14
3.75/3.75/7.00
3DT1FFE ? C 3D 7.5/3.5
1.10./1.10/
1.20
Head and necka Staging of primary and recurrent
tumors and follow-up of patients
with high risk of recurrence after
combined chemoradiotherapy
T2 FSE Axial 3528/90
050/071/3.00
T2,
3 DT1FFE
Dixon
1.11 ? 0.36 3.08
T1 FSE -/? C Axial 683/16
0.65/0.78/3.00
DWI (STIR, EPI) Axial 3876/260
1.98/2.02/3.00
STIR TSE Coronal 5040/80
(TI = 200)
0.60/0.80/4.00
3D T1 FFE
DixonWB ? C
3D 3.3/1.11/2.00
1.61/1.66/6.00
Prostatea Cancer staging in patients with a
positive biopsy
T2 FSE Axial,
sagittal
4400/120
0.50/0.56/3.00
4000/120
060/0.68/3.00
3D T2FSE 1.17 ? 0.36
WB
2.53
3DT2 FSE 3D 2000/181
0.51/0.51/3.00
DWI
0,500,1000,1500
b
Axial 3082/66
1.39/1.39/
3000
3DT1 FFE
Dixon ? C
3D 3.2/1.11/2.0
1.61/1.66/6.00
Dynamic thrive
(T1FFE) ? C
3D 6.9/3.4
073/0.73/1.50
aBreast Locoregional staging of primary and
recurrent breast tumors as well as the
detection of distant metastases
3DT1 FFE
(Dixon) -/? C
3D 5.9/1.42/2.6
0.67/0.67/1.00
3 DT1 FFE
Dixon
0.36 ? 0.36
WB
1.52
T2 FSE Axial 5000/120
059/059/3.00
Whole body
(WB)
Detection of distant metastases T2 FSE (5 times to
cover WB
Axial 3280/76
1.47/1.46/8.00
T2 FSE,
Dixon
WB
0.36
DWI Axial 3949/29
1.46/1.45/7.00
Dixon WB Axial 3.2/1.11/2.00
0.85/0.85/3.00
TSE turbo spin echo, SE: spin echo, DTI diffusion tensor imaging, DWI diffusion-weighted imaging, GE gradient echo, FLAIR Fluid Attenuated Inversion Recovery,
DCS dynamic susceptibility contrast, FFE fast field echo, STIR short TI inversion recovery, C contrast; TR repetition time, TE echo time, Res resolution
a Head and neck, prostate and breast are realized together with whole body PET-MR
b The total scanning time is the sum of the acquisition time of all sequences, whereas the total examination time includes—in addition to the scanning
time—patient positioning, injection of gadolinium, injection of radiotracer, table rotation and breaks between sequences
60 Magn Reson Mater Phy (2013) 26:57–69
123
2 mm for the Dixon sequence which enabled robust fat
suppression. The area covered was from the skull base to the
upper mediastinum (aortic arch) and the field of view was
24 cm. For all indications, the turbo spin echo sequences and
the Dixon sequence were obtained routinely whereas the 3D
Thrive sequence was performed only in oral cavity and
oropharyngeal tumors and if the tumor extended to the skull
base. Particular attention was paid to the phase encoding
gradient which was oriented in the anteroposterior direction
to avoid flow artifacts projecting to the pharynx and larynx.
Although placing the phase encoding gradient in the anter-
oposterior direction lengthens the duration of the sequence,
flow artifacts do not project to the areas of interest (typically
the larynx and pharynx), thus improving image quality
especially in the infrahyoid neck. The exam was monitored
by the attending radiologist who checked the correct place-
ment of all sequences as well as image quality. In the pres-
ence of major dyspnea and mucous secretions, patients were
asked to clear the throat and cough in between the sequences
and to refrain from coughing and swallowing vigorously
during sequence acquisition. In cases with severely degraded
image quality (5 out of 27 head and neck patients, 19 %), the
sequence was repeated after a short break and repeat instruc-
tions to the patient. This led to improved image quality in 4 of
the 5 cases (80 %), reducing the percentage of degraded image
quality to below 4 %. After the dedicated MRI examination of
the head and neck, the fat suppressed gadolinium-enhanced
Dixon sequence, as well as axial STIR images were acquired
on the chest and abdomen to search for distant metastases.
This was done using the integrated MR body coil.
For PET head and neck imaging, we administered
370 MBq of FDG for adult patients over 50 kg of weight,
and we used adapted doses for inferior weights (EANM
guidelines) [14]. The PET images were systematically
started 1 h after intravenous administration. PET acquisi-
tion spanning from the mid-thigh to the thorax was done in
1 min and 20 s per bed position, while the head and neck
region was explored with 2–3 bed positions lasting 6 min
each, in order to increase sensitivity and signal-to-noise
ratio. The datasets were reconstructed using a 3D listmode-
based TOF OSEM algorithm [16] with 3 subsets, 3 itera-
tions and a reconstruction resolution of 2 mm. MR images
obtained with the 3D THRIVE and the Dixon sequence
were fused with the images obtained from the PET
acquisition using the proprietary software (Philips Fusion
Viewer on Extended BrillianceTM Workspace) and Osirix
Medical software after which they were archived on the
PACS system (see Table 1).
Breast and female pelvis imaging
The indication for the realization of a PET/MRI in breast
(n = 36) was locoregional staging (Figs. 6, 7) of primary
and recurrent breast tumors, as well as the detection of
distant metastases. The MRI protocol included an axial T2
FSE(TE: 120 ms, TR 5000 ms) and a 3D T1 Dixon (TE1,
1.42 ms, TE2 2.6 ms, TR 5.9 ms) sequence acquired
immediately, 1 and 6 min after intravenous administration
of 0.2 ml/kg of a gadolinium chelate. Digital subtraction of
the water-only Dixon images was performed using the
dedicated MRI software and it is this sequence that was
interpreted together with the PET images.
Indications for PET/MRI in the female pelvis (n = 10)
were endometrial carcinoma and cervical cancer, mainly
for the delineation of uterine extension and lymph node
staging.
For PET-breast imaging, we administered 370 MBq of
FDG for adult patients over 50 kg of body weight; doses
were adapted for inferior weights (EANM guidelines)
[14]. Approximately 20–30 min later, we started the
dedicated breast MR sequences in prone position, using a
7-channel breast coil with a built-in template for PET
attenuation correction, followed by a prone PET acquisi-
tion of 2 min 15 s per bed position (usually 2). The PET
acquisition started systematically 1 h after FDG adminis-
tration. Reconstruction was performed using a 3D list-
mode-based TOF OSEM algorithm with 33 subsets and 3
iterations and a reconstruction resolution of 4 mm. Sub-
sequently, a supine whole-body MR and PET (1 min 20 s
per bed, from the feet towards head) were acquired.
Fusion of the subtraction MR sequence and PET data was
done routinely using the dedicated PET/MRI software
(Philips Fusion Viewer on Extended BrillianceTM Work-
space) as well as Osirix Medical fusion software (see
Table 1).
Prostate imaging
The main indication for PET/MRI was prostate cancer
staging in patients with a positive biopsy (75 %) (Figs. 8,
9). Other indications included the assessment of tumor
recurrence after treatment in patients with increasing serum
prostate specific antigen (PSA) (15 %), and tumor detec-
tion in patients with increased PSA but negative biopsies
(10 %). The following protocol was used: axial and sagittal
T2-weighted fast spin echo (FSE, TE 120 ms, TR
4400 ms) sequence with a resolution of 0.3 9 0.3 9 3 mm
using both an endorectal and the 6-channel SENSE cardiac
coil. After removal of the endorectal coil, the following
MR acquisitions were performed using a phased array coil
only: a 1 mm isotropic T2 3D fast spin echo (TE 181 ms,
TR 2000 ms), an axial diffusion-weighted sequence with b
values 0, 500, 1000 and 1500, as well as a dynamic 3D T1
fat saturated field echo sequence (TE 3,4 ms, TR 6,9 ms)
during the injection of Gd contrast agent (Dotarem
0.1 mmol/kg). Finally, using the integrated body coil, 5
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batches of 3D T1 fat saturated field echo sequence were
acquired on the upper abdomen to search for lymph
nodes.
For PET-imaging of the prostate we adapted the proto-
col previously validated for PET/CT investigations [14].
Scanning started with a dynamic acquisition of 10 min
centered on the prostate with the injection of 300 MBq of
18F-Fluorocholine, followed by a whole-body acquisition
(1 min 20 s per bed, from feet toward head), and subse-
quently by a dedicated 2 bed acquisition on the pelvis,
lasting 5 min per bed. These images were reconstructed
using a 3D listmode-based TOF OSEM algorithm with 33
subsets, 3 iterations and a reconstruction resolution of
4 mm.
Problems and limitations common to all examinations
The following problems were encountered:
Scanning time
In order to decrease scanning time, each protocol was
adapted to decrease the number of sequences to the mini-
mum necessary for diagnosis. This was done after retro-
spective analysis of the available cases. For example, in the
head and neck, the total body MRI protocol for the
detection of distant metastases included a STIR sequence
and a Dixon sequence after the intravenous administra-
tion of Gadolinium. After retrospective analysis of all
Fig. 2 Patient with glioblastoma at the mesencephalon level; note the enhancement (a), the increase of metabolism of the18F fluoroethyl-L-
tyrosine on fused PET/MRI-images (b) and the cortico-spinal tract fibers displaced by the tumor on the tractography sequence (c)
Fig. 3 Artifacts of
inhomogeneity and movement,
in a patient wearing an MR-
compatible EEG recording
system. The PET/MRI
examination was performed for
presurgical evaluation of
epilepsy and for this reason
associated with EEG
monitoring. Artifacts of
inhomogeneity of signal are
illustrated on an axial FLAIR
image (a) with associated
motion artifacts. Axial FLAIR
sequence of the same patient
obtained 15 days earlier on
other scanner (b)
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available head and neck cases, we found that the STIR
sequence for the chest and abdomen did not yield addi-
tional information, as compared to the Dixon sequence
and the PET acquisition. Consequently, we do not perform
the STIR sequence anymore to look for distant metastases
but instead rely on the Dixon and fused PET-Dixon
sequence. Further analysis of cases will also help to
identify other MRI sequences that might be redundant
when the metabolic-molecular information of PET is
available, obtaining additional reduction in the duration of
the entire exam. Nevertheless, the long scanning time
remains a serious problem in clinical practice, particularly
in patients with pain, dyspnea, dysphagia and cognitive
problems. In cases where full patient cooperation is
possible, such as in the head and neck, short pauses
between the sequences, where patients can cough and
Fig. 4 PET/MRI with FDG obtained in a patient with a tumor of the
mouth floor. The contrast enhanced T1-weighted MR images are
shown in a, whereas the image fusion between the T1-weighted
images and the PET acquisition is shown in b. The tumor invades the
anterior floor of the mouth bilaterally (arrows) extending into the
sublingual spaces and the geniohyoid muscles. There is an abnormal
level 2 lymph node on the left, as seen on the MR image (c, arrow).
Note the perfect match between the PET and the MRI images both for
the tumor and for the lymph node, which show an increased
metabolism (arrows on d). Histology revealed squamous cell
carcinoma
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Fig. 5 PET/MRI with FDG obtained in a patient with suspected
recurrence after chemoradiotherapy. T1-weighted contrast-enhanced
axial MR image (a) and corresponding fused PET MRI image (b).
The MR image shows a recurrent tumor arising from the hypopharynx
(white arrows). Due to patient movement, the PET image is displaced
anteriorly (dashed arrow) resulting in poor PET MR fusion. Based on
the fused image, one would interpret the hypermetabolic area in the
larynx at the level of the right vocal cord and at the level of the
posterior commissure (yellow arrow) as a recurrent tumor, whereas
the MR image clearly indicates that the recurrent tumor is not in the
larynx but in the hypopharynx, therefore having a major impact on the
surgical resection. Surgical biopsy confirmed tumor recurrence within
the hypopharynx
Fig. 6 Invasive ductal
carcinoma of 12 mm of size
with perfect fusion between
MRI and PET-FDG and very
good correlation with pathology
Fig. 7 Invasive lobular carcinoma of 50 mm of size (a); note slight defect of fusion between MRI and PET-FDG images (arrow, b)
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clear the throat are a potential solution to avoid
subsequent motion artifacts and poor image quality.
These short breaks enable patients to refrain from vigor-
ous coughing during scanning but increase the overall
duration of the exam. While it is true that these short breaks
might potentially increase misalignment, they are abso-
lutely necessary in order to achieve good quality MR
images.
Motion artifacts
This type of artifact was mainly observed in long studies
(Fig. 3). It was partially solved by decreasing the total
number of sequences and by using motion correction
algorithms [17, 18]. We also used contention devices and
tried to use body positions in which the patient was the
most comfortable (i.e. arms down instead of the arms up
Fig. 8 Effect of the endorectal coil on the PET/MRI registration. On
the left, axial T2 images of a prostate with a large right peripheral
zone cancer, as demonstrated by a hypointense area. The tumor is
visible on both the T2-weighted images acquired with an endorectal
coil (row a left) and on the images obtained with an external phased-
array coil (row b left). On the PET images, the tumor is characterized
by an increased 18F-Fluorocholine metabolism. The fusion between
the T2-weighted images and the PET images is not accurate when the
T2-weighted images are acquired with an endorectal coil. Using an
external phased array coil results in an almost perfect matching
between the PET and T2 images
Fig. 9 Example of correct and low quality fusion of PET and MRI
images due to different bladder filling. In the upper row, PET data
were acquired after the MRI data and bladder distension was more
important on the PET images, resulting in an inaccurate fusion of both
imaging modalities. As a result, the PET with 18F-Fluorocholine
signal uptake of the abnormal lymph node just behind the right
seminal gland is shifted posteriorly. This misregistration related to
bladder filling was solved by restricting water intake 4 h before the
PET/MRI exam and by asking the patient to void just before
beginning the image acquisition. This simple measure ensures a
correct fusion in most cases as demonstrated in the lower row. Please
note the perfect matched MRI and PET signal from the bladder as
well as from the bone metastasis in the right pubic ramus
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position that is used for PET/CT). We also routinely
explain to the patients the importance of the absence of
movement in order to increase their awareness and obtain
the best possible collaboration.
Quality control
The PET scanner detector pairs are inherently not uniform
in PET systems due to a systematic variation of detector
pair geometry from the center to the periphery of the FOV,
a drift in photomultiplier gains and nonuniform sampling
across the FOV [19].
Therefore, daily automated calibrations of the PET elec-
tronics have to be performed, which include the following:
(1) voltage and current tests for the PET gantry electronics to
ensure accurate digitization of the signal; (2) baseline
correction for the analog offsets of the photomultiplier
channels and gain calibration to ensure that all photomulti-
pliers amplify equally; (3) a timing test for the time-of-flight
circuitry. After these hardware calibrations, emission sino-
grams are collected in order to identify system drifts
affecting image quality and/or defective hardware.
Monthly quality controls are performed by physicists for
PET and MRI to ensure uniformity of the system over the
entire FOV and to calibrate and validate standardized
uptake values (SUVs) so that subsequent patient scans can
be quantified properly.
Accurate image fusion in PET/MRI
Initial system calibration
For the successful fusion of PET and MRI images, the
physics of the MR device needs to be taken into account.
Unlike in CT and PET, where the absolute image position is
largely determined by the hardware, the center of an MR
image depends on accurate determination of the Larmor
frequency of the spins, f0. This calibration is automatically
performed at the beginning of each MR acquisition but may
be less reliable in the presence of heavy frequency differ-
ences across the FOV (i.e. broad frequency peak if materials
containing metal are used). Therefore, in order to perform
initial image alignment calibrations, probes that are visible
on MR and PET [20] consisting of MR compatible materials
were chosen by the vendor. This allows accurate frequency
determination and avoids image distortions of the MR image,
which can occur in addition to positioning offsets.
Patient scans
MR images are prone to suffer from distortions which
occur both from machine-dependent and patient-dependent
effects, such as magnetic field inhomogeneities, chemical
shift and eddy currents [21]. Applications of paired positive
and negative (bipolar) gradients, as well as twice refocused
spin-echo sequences can be used to minimize eddy current
effects, for example in diffusion-weighted sequences,
whereas when using spin-echo sequences instead of gra-
dient echo sequences, one can minimize distortions that are
induced by differences in susceptibility (i.e. at the air/tissue
interfaces, metal implants). Setting a large receiver band-
width helps to reduce chemical shift artifacts that may
occur when different resonant frequencies are present in
the FOV (i.e. water and fat), albeit at the expense of a
reduced SNR and longer scan times.
These sequence-, hardware- and patient-related effects
need to be taken into account when acquiring MR images that
will be fused with PET. Whereas machine-related effects are
corrected for using a phantom of known geometry during
system calibration, patient-related effects have to be taken
care of by using dedicated correction algorithms in the fusion
software and adapted MR sequence parameters. To reduce
patient-related effects and to minimize fusion artifacts on our
system, we used Dixon sequences for whole-body and H/N
PET/MRI scans [22]. Using this sequence, the chemical shift
offsets between water and fat are corrected for during the
reconstruction process so that the absolute image position of
both the water and fat images are correct. This then leads to an
improved image overlay between all types of Dixon MRI
images (water, fat, in-phase and out-of-phase) and PET ima-
ges. In addition to the Dixon sequence, spin-echo sequences
proved to be particularly robust for imaging the H/N area.
General MR artifacts
MRI artifacts observed in our hybrid PET/MRI system were
similar to MRI artifacts reported in dedicated non-hybrid MRI
units [22] and included magnetic susceptibility artifacts,
blood-flow artifacts, and homogeneity artifacts. We did not
observe any truncation or Gibbs artifacts in the current series.
In a recent study evaluating 2,705 brain MRI studies per-
formed on a 3T machine from a different vendor [23], the
authors found that among all artifacts identified, 29 % were
magnetic susceptibility artifacts, 57 % were pulsation arti-
facts, 3 % were homogeneity artifacts, and 6 % motion arti-
facts [22]. In the current series of 29 brain studies, we have
observed these artifacts in four patients (14 %). They typically
occurred on the 3DT1, 3DFLAIR and ASL sequences.
Data regarding the prevalence of artifacts in hybrid PET/
MRI systems in larger clinical series are currently lacking.
Delso et al. [24] reported a good overall performance of a
simultaneous integrated PET/MRI system (Biograph mMR,
Siemens) during independent and simultaneous acquisition
of MRI and PET data on a phantom. In particular, spatial
resolution, scatter fraction, count losses, image quality,
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geometric accuracy, signal to noise ratio, field homogene-
ity and radiofrequency noise were within the tolerances
defined by the American College of Radiology; the results
were also similar to data of state-of-the-art PET/CT scan-
ners with regard to the PET acquisition. However, in vivo
measurements were performed only in one patient and in a
single healthy volunteer [24].
Technical staff
In our setting, the hybrid PET/MRI is operated by two
technicians in the routine clinical setting while physicists
assist with the development and implementation of new
sequences before these are used in clinical routine. While
in Switzerland technicians are trained and certified to
operate both nuclear medicine and radiological devices, we
elected to match two teams of experienced technologists
with different backgrounds: one group of technologists
with at least two years of clinical experience in MRI
imaging and one with a similar specific experience in PET
imaging. On site technician training can be lengthy, as each
technician had to learn the basic principles of the technique
that he did not routinely perform prior to the introduction
of the PET/MRI machine in our department. This required
instruction by specialized personnel in order to provide the
needed special training of theoretical and practical aspects
of MRI physics, nuclear medicine principles and applica-
tions, as well as radioprotection issues. In addition, the
supervision of the exam required a complex organization
structure because both modalities had to be checked and
supervised by different individuals of the multidisciplinary
team for accurate positioning of MRI sequences in view of
optimized protocols. Although it is very difficult to esti-
mate the added burden of such organization, it is clear that
at the current stage of development of this new technique,
each PET/MRI exam needs to be tailored and monitored to
ensure adequate diagnostic quality and therefore requires
supervision by the medical staff, in particular for adapting
the protocol depending on radiologic findings and patient
cooperation. Close collaboration between the medical and
technical teams as well as physics staff of both departments
of Nuclear Medicine and Radiology is essential to assure
the shortest possible examination time, while providing the
best quality of each modality to insure adequate quality for
joint image interpretation.
Specific problems inherent to each organ system
Nervous system
For nervous system examinations, the most relevant spe-
cific problems that were encountered included the long
scanning time, susceptibility artifacts (two cases due to an
implant (ventriculo-peritoneal drain) and motion artifacts
(two cases) (Fig. 3). They typically occurred in the 3DT1,
3DFLAIR and ASL sequences.
Gynecological imaging
For gynecological imaging, the most relevant problems
encountered were due to occasional misalignment fusion
artifacts (Fig. 7). In the lower abdominal region, motion
and organ shift would result in misalignment of PET and
MR images.
Head and neck imaging
Due to the choice of the phase encoding gradient in the
anteroposterior direction, flow related artifacts over the
relevant areas to be assessed (pharynx and larynx) were
practically nonexistent and yielded images of good and
reproducible image quality. This was of particular
importance for the interpretation of MR studies involving
tumors of the larynx, hypopharynx or oropharynx [25].
Similar to data published in the literature [25], we found
that spin echo sequences were particularly robust to
motion caused by swallowing and breathing and to field
inhomogeneity caused by air–soft tissue interfaces. Unlike
spin echo sequences, gradient echo sequences require
gradients to dephase and rephase the spins to create the
signal echo. They are therefore more sensitive to inho-
mogeneities since spin dephasing is then not compensated
with the refocusing gradients. This leads to a lower SNR
than in spin echo sequences. Of the 27 patients who
underwent a PET/MRI examination, images were con-
sidered to be of poor quality only in three cases (11 %)
due to major patient movement and subsequently poor
fusion, making interpretation of images nearly impossible.
In addition, slight motion or changes in the head and neck
position between the MR and the PET acquisition resulted
in suboptimal fusion (Fig. 5) in four cases (15 %), in
particular when dealing with small structures such as
lymph node metastases inferior to 1 cm or small sized
head and neck tumors (maximum diameter less than
2 cm). One particular problem was that due to the
impaired fusion quality, it became very difficult to esti-
mate the size of the tumor (delineation with MRI alone or
with fused PET MR was more precise) (Fig. 5). Suscep-
tibility artifacts related to dental fillings and implants are
a problem that may typically occur in the head and neck.
They are seen not only on the diagnostic MRI images but
also propagate on the atMRI. In our series, we observed
severe artifacts related to dental implants in four head and
neck cases (15 %). However, evaluation of tumor spread
was not possible only in one case (3 %), in which a
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previous CT and a 1.5 T MRI were also nondiagnostic
with respect to precise presurgical evaluation of submu-
cosal tumor extent.
Prostate imaging
Regarding prostate hybrid imaging, the most important
artifacts were related to patient motion during the exami-
nation. Special instructions were given to patients to avoid
voluntary movements during the acquisition. In clinical
routine, the endorectal coil was removed after anatomical
T2 acquisition to decrease motion related to the patient
discomfort. In addition, removing the endorectal coil
decreased susceptibility artifacts in the posterior zone of
the prostate mainly on the diffusion-weighted MRI
sequence, resulting in an improved image quality. Our tests
showed that when T2 MRI images are acquired with the
endorectal coil in place, the registration between PET and
MR images is inaccurate (Fig. 8). Therefore, whole-body
T2 images used for attenuation correction and for
anatomical localization are acquired after endorectal coil
removal while using an external phased array coil. In order
to avoid blurred images due to bowel movement, anti-
peristaltic drugs (Buscopan) were routinely administered
subcutaneously. During the first cases that we examined,
we observed that filling of the bladder during the hybrid
exam may result in poor alignment of MRI and PET
images of the prostate region (Fig. 9). We are therefore
now asking the patients to stop drinking 4 h before the
exam and to void their bladder before starting the exam.
Conclusion
PET/MRI is a recent technique increasingly used in clinical
practice with two main advantages: first, reduction of total
radiation dose by avoiding the CT acquisition necessary in
hybrid PET/CT machines, and second, combined metabolic
and anatomical information in a single imaging session
taking advantage of the superior soft tissue characterization
of MRI over CT.
The results of our first clinical experience show that in
order to achieve optimum impact and ensure clinical
acceptance of this exciting new technology it is necessary
to adapt and fine-tune existing imaging protocols to insure
optimal diagnostic quality of both techniques during the
acquisition of hybrid PET/MRI examination. In our insti-
tution, this was done by carefully monitoring the examin-
ations while they were being performed: a joint effort of a
multidisciplinary team consisting of technologists, radiol-
ogists, nuclear medicine specialists and application physi-
cists was necessary to reach our goal.
For the MRI system, we mainly encountered artifacts
related to metal implants and patient motion. The fre-
quency of motion artifacts can be reduced by shortening
the examination time, and optimizing imaging workflow
and protocols. Simple tricks such as the use of robust
sequences (spin echo and Dixon), breaks between the
acquisition of sequences in dyspneic and coughing patients,
anteroposterior phase encoding in the head and neck,
administration of Buscopan, early removal of the endo-
rectal coil and voiding the bladder before the exam in
prostate cancer patients allow to obtain adequate results
and good image quality in most patients. Furthermore, to
obtain optimal image quality, it is important to apply
meticulous daily quality control procedures of PET scanner
calibration, as well as accurate MRI and PET alignment
calibration.
We have reported herewith our first clinical experi-
ence with hybrid PET/MRI in a large series of patients
referred for both diagnostic PET and MR procedures.
The optimized protocols used to evaluate a variety of
pathologies, and simple tricks and recommendations to
improve image quality are presented and discussed.
Further evaluation of clinical data and controlled studies
evaluating the correlation with histology or patient out-
come will show whether this new technology will have a
significant impact on patient management compared to
current state PET/CT, where these two types of imaging
procedures are acquired separately on different devices at
different points in time.
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